P

P

Lord Jesus Christ Says...

“And so I tell you, keep on asking, and you will receive what you ask for. Keep on seeking, and you will find. Keep on knocking, and the door will be opened to you. For everyone who asks, receives. Everyone who seeks, finds. And to everyone who knocks, the door will be opened.” Jesus Christ, Luke 11:9-10

19 Mar 2016

STOCK MARKET- PHARMA SHARES EXTEND FALL; LUPIN NEARS 52-WEEK LOW.



Shares of pharmaceutical companies remained under pressure in monring deals on Friday, with most of the frontline stocks trading lower by over 2% on the BSE.
Sun Pharmaceutical Industries, Lupin, Aurobindo Pharma and Natco Pharma were down more than 3% each, while Wockhardt, Glenmark Pharmaceuticals, Indoco Remedies and Ajanta Pharma down between 2%-3% on the BSE.

At 09:57 AM, the S&P BSE Healthcare index was down nearly 2% as compared to 0.24% rise in the S&P BSE Sensex.

In past four trading sessions, the pharma index underperforming the market by falling 5.7% as United States Food and Drug Administration (USFDA) observations on Lupin’s plant is overhangs for pharma companies. The benchmark index reported a marginal 0.31% decline during the same period.

Lupin has dipped nearly 5% to Rs 1,598, its lowest level since July 29, 2015 on the BSE. The stock trading at close to its 52-week low of Rs 1,589 touched on May last year during intra-day trade.

In past four trading sessions, the share of drug maker has fallen 14% from Rs 1,869 after the company on Tuesday said that the United States Food and Drug Administration (USFDA) inspected Lupin’s Goa facility last week and cited 9 observations.

The observations are on aspects such as inadequacy and adherence to standard operating procedures and we are in the midst of putting together a response to address the USFDA’s observations, Lupin said on a clarification on
In past four trading sessions, the pharma index underperforming the market by falling 5.7% as United States Food and Drug Administration (USFDA) observations on Lupin’s plant is overhangs for pharma companies. The benchmark index reported a marginal 0.31% decline during the same period.
Lupin has dipped nearly 5% to Rs 1,598, its lowest level since July 29, 2015 on the BSE. The stock trading at close to its 52-week low of Rs 1,589 touched on May last year during intra-day trade.
In past four trading sessions, the share of drug maker has fallen 14% from Rs 1,869 after the company on Tuesday said that the United States Food and Drug Administration (USFDA) inspected Lupin’s Goa facility last week and cited 9 observations.
The observations are on aspects such as inadequacy and adherence to standard operating procedures and we are in the midst of putting together a response to address the USFDA’s observations, Lupin said on a clarification on news report.


Name
14/03/2016
LTP
% chg
Lupin
1868.50
1616.00
-13.51
Natco Pharma
504.55
452.45
-10.33
Wockhardt
994.60
930.00
-6.50
Sun Pharma
864.00
809.65
-6.29
Sanofi India
4427.45
4155.00
-6.15
Pfizer
1760.80
1655.00
-6.01
Ajanta Pharma
1416.75
1333.00
-5.91
Abbott India
4866.75
4630.25
-4.86
Glenmark Pharma.
830.85
791.15
-4.78
Divi's Lab.
1011.60
970.75
-4.04
Dr Reddy's
3234.35
3117.50
-3.61
Aurobindo Pharma
735.10
709.00
-3.55
Strides Shasun
1063.85
1030.60
-3.13
Cipla
538.05
522.45
-2.90
Cadila Health.
348.55
339.00
-2.74




Sensex
24804
24803
0.0
Healthcare index
16024
15181
-5.3




LTP : Last traded price on BSE in Rs at 10:09 AM.



No comments:

Post a Comment